Assignee
GALAPAGOS NV
BE64 patents
Top patents by PatentIndex Score
US10328081B2Jun 25, 2019
Compound useful for the treatment of degenerative and inflammatory diseases
GALAPAGOS NV9 citations92
US9309244B2Apr 12, 2016
Compound useful for the treatment of degenerative and inflammatory diseases
GALAPAGOS NV14 citations92
US8999979B2Apr 7, 2015
Compound useful for the treatment of degenerative and inflammatory diseases
GALAPAGOS NV15 citations92
US9249141B2Feb 2, 2016
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV9 citations91
US9382247B2Jul 5, 2016
Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV12 citations89
US11000528B2May 11, 2021
Compound useful for the treatment of degenerative and inflammatory diseases
GALAPAGOS NV7 citations83
US10526329B2Jan 7, 2020
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV4 citations83
US10125132B2Nov 13, 2018
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV6 citations83
US9670204B2Jun 6, 2017
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV10 citations83
US8993590B2Mar 31, 2015
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV8 citations83
US7915256B2Mar 29, 2011
Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
GALAPAGOS NV12 citations83
US7501411B2Mar 10, 2009
Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
GALAPAGOS NV12 citations83
US10206907B2Feb 19, 2019
Compounds useful for the treatment of degenerative and inflammatory diseases
GALAPAGOS NV4 citations82
US9255095B2Feb 9, 2016
Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV6 citations82
US8927543B2Jan 6, 2015
Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV6 citations82
US11667633B2Jun 6, 2023
Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV4 citations81
US9926281B2Mar 27, 2018
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
GALAPAGOS NV6 citations81
US9133210B2Sep 15, 2015
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
GALAPAGOS NV4 citations81
US10708263B2Jul 7, 2020
Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV5 citations79
US10919890B2Feb 16, 2021
Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV4 citations75
US11072611B2Jul 27, 2021
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV2 citations72
US7332337B2Feb 19, 2008
Viral vectors having tissue tropism for T-lymphocytes, B- and mast cells
GALAPAGOS NV20 citations72
US10047083B2Aug 14, 2018
Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV2 citations71
US10568867B2Feb 25, 2020
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
GALAPAGOS NV1 citations70
US10487060B2Nov 26, 2019
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
GALAPAGOS NV4 citations70
US10376520B2Aug 13, 2019
Methods for the treatment of cardiovascular disorders
GALAPAGOS NV4 citations70
US9351955B2May 31, 2016
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
GALAPAGOS NV3 citations70
US7306923B2Dec 11, 2007
Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases
GALAPAGOS NV7 citations70
US11564923B2Jan 31, 2023
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV2 citations68
US11339166B2May 24, 2022
Compounds and pharmaceutical compositions thereof for the treatment of diseases
GALAPAGOS NV2 citations68
US9895347B2Feb 20, 2018
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
GALAPAGOS NV3 citations67
US10493158B2Dec 3, 2019
Pharmaceutical compositions for the treatment of inflammatory disorders
GALAPAGOS NV4 citations64
US7429459B2Sep 30, 2008
Methods for identifying a compound that inhibits the procession of amyloid-beta protein production in a mammalian cell expressing APP and overexpressing a G-protein coupled receptor in the cell
GALAPAGOS NV8 citations64
US11220499B2Jan 11, 2022
Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV0 citations60
US8012983B2Sep 6, 2011
Substituted triazolopyrazines useful for the treatment of degenerative and inflammatory diseases
GALAPAGOS NV4 citations60
US7638288B2Dec 29, 2009
Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts
GALAPAGOS NV2 citations60
US7615626B2Nov 10, 2009
Methods, agents, and compound screening assays for inducing differentiation of undifferentiatied mammalian cells into osteoblasts
GALAPAGOS NV1 citations60
US11975008B2May 7, 2024
Pharmaceutical compositions comprising a JAK inhibitor
GALAPAGOS NV0 citations59
US11718588B2Aug 8, 2023
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
GALAPAGOS NV0 citations59
US10941117B2Mar 9, 2021
5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
GALAPAGOS NV0 citations59
US12065443B2Aug 20, 2024
Compounds and pharmaceutical compositions thereof for the treatment of diseases
GALAPAGOS NV0 citations58
US7968581B2Jun 28, 2011
Imidazolidine compounds as androgen receptor modulators
GALAPAGOS NV2 citations58
US9382254B2Jul 5, 2016
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
GALAPAGOS NV2 citations57
US12472181B2Nov 18, 2025
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV0 citations56
US11136325B2Oct 5, 2021
Pyrrolopyrimidine and pyrrolopyridine derivatives
GALAPAGOS NV0 citations56
US9440929B2Sep 13, 2016
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV2 citations56
US10568879B2Feb 25, 2020
Dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV1 citations54
US8883425B2Nov 11, 2014
Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
GALAPAGOS NV1 citations54
US9796719B2Oct 24, 2017
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV1 citations51
US9708312B2Jul 18, 2017
Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders (GPR84 antagonists)
GALAPAGOS NV1 citations50
Showing the top 50 of 64 patents by PatentIndex Score.